维普中文期刊产品整合服务
28篇 您的检索式:作者名="Macut"
    题名 作者 年代 出处 被引量
1Leptin and human reproduction 显示文摘Macut D Micic D 1998Med Pregl1998,51,910:1
2Adipokines, insulin resistance and hyperandrogene-mia in obese patients with polycystic ovary syndrome:cross-sectional correlations and the effects of weight loss显示文摘Spanos N Tziomalos K Macut D 2012Obes Facts2012,5,4:1
3Cardiovascalar risk in adolescent and young adult, obese females with polycystic ovary syndrome显示文摘 Micic D Cvijovic G 2001J Pediat Endocrinol2001,14,5:1
4Cardiac nitric ox- ide synthases and Na+/K+-ATPase in the rat model of polyeystic ovary syndrome induced by dihydrotestosterone显示文摘Tepavcevic S Milutinovic DV Macut D 2015Exp Clin En- docrinol Diabetes2015,123,5:1
5Dihydrotestosterone deteriorates cardiac insulin signaling and glucose transport in the rat model of polycystic ovary syndrome显示文摘TEPA VCEVIC S VOJNOVIC M D MACUT D 2014J Steroid Biochem Mol Biol2014,141,:1
6Possible involvement of glucocorticoids in 5alpha-dihydrotestosterone-induced PCOS-like metabolic disturbances in the rat visceral adipose tissue显示文摘NIKOLIC M MACUT D DJORDJEVIC A et ai 2015Mol Cell Endocrinol2015,399,:1
7Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss显示文摘Spanos N Tziomalos K Macut D 2012Obes Facts2012,5,4:1
8Adipokines, insulin resistance and hyperandrogenemia in obese patients with polyeystic ovary syndrome: cross-sectional correlations and the effects of weight loss显示文摘Spanos N Tziomalos K Macut D 2012Obes Facts2012,5,4:1
9显示文摘Macut D 1998Med Pregl1998,51,:1
10Insulin resistance in non - obese women with polycystic ovary syndrome:relation to byproducts of oxida- tive stress 显示文摘Macut D Simic T Lissounov A 2011Exp Clin Endocrinol Diabetes2011,119,7:1
11The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary- adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome显示文摘Macut D Bozic Antic Nestorove J 2015Hormones(Athens)2015,14,1:1
12Adipokines,insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome : cross-sectional correlations and the effects of weight loss显示文摘Spanos N Tziomalos K Macut D 2012Obes Facts2012,5,4:1
13Insulin resistance in non - obese women with polycystic ovary sundrome:relation to byproducts of oxidative stress显示文摘Macut D Simic T Lissorunov A 2011Exp Clin Endocrinol Diab2011,119,7:1
14Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndrome 显示文摘Panidis D Macut D Farmakiotis D 2006Eur J Obstet Gynecol2006,127,:1
15Oxidised low - density lipo- protein concentration - early marker of an altered lipid metabolism in young women with PCOS 显示文摘Macut D Damjanovic S Panidis D 2006Eur J Endoerinol2006,155,:1
16Insulin resistance in nonobese women with polycystic ovary syndrome:relation to byproducts of oxidative stress显示文摘Macut D Simic T Lissounov A 0,,07:1
17Cross-sectional anal- ysis of the effects of age on the hormonal,metabolic,and ul!ra- sonographic features and the prevalence of the different pheno- types of polycystic ovary syndrome显示文摘Panidis D Tziomalos K MacUt D 2012Fertility and Sterility: Official Journal of the American Fertility Society Pacific Coast Fertility Society and the Canadian Fertility and Andrology So ciety2012,97,02:1
18Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome 显示文摘Micic D Macut D Popovic V 1997Gynecol Endocrinol1997,11,5:1
19Lipid and lipoprotein profile in women with polycystic ovary syndrome显示文摘Macut D Panidis D Glisic B 2008Can J Physiol Pharmaeol2008,86,4:1
20Somatostatin receptor scintigraphy in the follow up of neuroendocrine neoplasms of appendix显示文摘BACKGROUND Neuroendocrine tumors of appendix(ANETs)known as carcinoids,are rare endocrine neoplasms originated from enterochromaffin cells of gastrointestinal tract.ANETs are the third most frequent(16.7%)gastrointestinal neuroendocrine tumors,with the incidence of 0.08-0.2 cases/100000 during one year.Incidental ANETs occur in 0.2%-0.7%of emergency surgical resections because of suspected appendicitis which is usually the first manifestation of ANET.Although there are a lot of papers about application of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumors,there are very rare sporadic cases described about ANETs particularly.AIM To establish the role of somatostatin receptor scintigraphy(SRS)in the management of patients with neuroendocrine tumors of appendix(ANET).METHODS The total of 35 patients was investigated,23 females and 12 males,average age(43.7±17.3 years).All patients had histological diagnosis of ANET(34 carcinoids of appendix and one tubular carcinoid).Majority of tumors have been found incidentally during surgery of:Acute appendicitis(n=15),perforated appendicitis(n=2),ileus(n=3),hysterectomy(n=3),ruptured ovarian cyst(n=2),caecal volvulus(n=1),while 9 patients had diagnosis of appendiceal tumor before the surgery.Seventeen patients had tumor grade(G)G1,12 G2 and 6 G3.The right hemicolectomy was performed in 13,while the rest of the patients had appendectomy only.SRS was done early(2 h)and late(24 h)after i.v.application of 740 MBq technetium-99 m ethylenediamine-N,N’-diacetic acid Hydrazinonicotinyl-Tyr3-Octreotide(technetium-99 m-Tektrotyd,Polatom,Poland).SRS was performed for restaging in all the patients after surgery.RESULTS There were 12 true positive(TP),19 true negative,3 false positive and 1 false negative SRS result.Sensitivity of the method was 92.31%,specificity was 86.36%,positive predictive value was 80.00%,negative predictive value was 95.00%and accuracy 88.57%.Receiver operating characteristics analysis showed that SRS scintigraphy is a good test for detection TP cases[area under the curve of 0.850,95%confidence interval(CI):0.710-0.990,P<001].Single photon emission computed tomography contributed diagnosis in 7 TP findings.In 10 patients Krenning score was 4 and in 2 was 3.In 8 patients SRS significantly changed the management of the patients(in two surgery was repeated,in 4 somatostatin analogues and in two peptide receptor radionuclide therapy).Median progression-free survival in SRS positive patients was 52 months(95%CI:39.7-117.3 mo)while in SRS negative patients it was 60 months(95%CI:42.8-77.1 mo),without statistically significant difference between the two groups(P=0.434).CONCLUSION In conclusion,our results confirmed the value of SRS in the follow-up of the patients with ANET after surgery,if recurrences or metastases are suspected.Jelena Saponjski Djuro Macut Dragana Sobic-Saranovic Sanja Ognjanovic Ivana Bozic Antic Djordje Pavlovic Vera Artiko 2020World Journal of Clinical Cases2020,8,17:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费